These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 28165806)
21. Comparative pharmacokinetic studies of borneol in mouse plasma and brain by different administrations. Zhao JY; Lu Y; Du SY; Song X; Bai J; Wang Y J Zhejiang Univ Sci B; 2012 Dec; 13(12):990-6. PubMed ID: 23225854 [TBL] [Abstract][Full Text] [Related]
22. The mechanism of the opening of the blood-brain barrier by borneol: a pharmacodynamics and pharmacokinetics combination study. Yu B; Ruan M; Dong X; Yu Y; Cheng H J Ethnopharmacol; 2013 Dec; 150(3):1096-108. PubMed ID: 24432371 [TBL] [Abstract][Full Text] [Related]
23. HP-β-CD-PLGA nanoparticles improve the penetration and bioavailability of puerarin and enhance the therapeutic effects on brain ischemia-reperfusion injury in rats. Tao HQ; Meng Q; Li MH; Yu H; Liu MF; Du D; Sun SL; Yang HC; Wang YM; Ye W; Yang LZ; Zhu DL; Jiang CL; Peng HS Naunyn Schmiedebergs Arch Pharmacol; 2013 Jan; 386(1):61-70. PubMed ID: 23192284 [TBL] [Abstract][Full Text] [Related]
24. Fabrication of Fine Puerarin Nanocrystals by Box-Behnken Design to Enhance Intestinal Absorption. Cheng M; Yuan F; Liu J; Liu W; Feng J; Jin Y; Tu L AAPS PharmSciTech; 2020 Feb; 21(3):90. PubMed ID: 32060654 [TBL] [Abstract][Full Text] [Related]
25. Multiple regulation and targeting effects of borneol in the neurovascular unit in neurodegenerative diseases. Chen N; Wen J; Wang Z; Wang J Basic Clin Pharmacol Toxicol; 2022 Jan; 130(1):5-19. PubMed ID: 34491621 [TBL] [Abstract][Full Text] [Related]
26. N-trimethyl chitosan (TMC)-modified microemulsions for improved oral bioavailability of puerarin: preparation and evaluation. Liao D; Liu X; Dai W; Tang T; Ou G; Zhang K; Han M; Kang R; Yang S; Xiang D Drug Deliv; 2015; 22(4):516-21. PubMed ID: 24467620 [TBL] [Abstract][Full Text] [Related]
27. Enhanced oral bioavailability of valsartan in rats using a supersaturable self-microemulsifying drug delivery system with P-glycoprotein inhibitors. Goo YT; Song SH; Yeom DW; Chae BR; Yoon HY; Kim CH; Park SY; Kang TH; Lee S; Choi YW Pharm Dev Technol; 2020 Feb; 25(2):178-186. PubMed ID: 31631736 [TBL] [Abstract][Full Text] [Related]
28. Comparative pharmacokinetics of borneol in cerebral ischemia-reperfusion and sham-operated rats. Xu P; Li Y; Du SY; Lu Y; Bai J; Guo QL J Zhejiang Univ Sci B; 2014 Jan; 15(1):84-91. PubMed ID: 24390748 [TBL] [Abstract][Full Text] [Related]
29. A microemulsion of puerarin-phospholipid complex for improving bioavailability: preparation, in vitro and in vivo evaluations. Wu JY; Li YJ; Han M; Hu XB; Yang L; Wang JM; Xiang DX Drug Dev Ind Pharm; 2018 Aug; 44(8):1336-1341. PubMed ID: 29513046 [TBL] [Abstract][Full Text] [Related]
30. Tanshinol borneol ester on nanostructured lipid carriers has longer brain and systemic effector retention and better antioxidant activity in vivo. Yuan X; Fei F; Sun H; Xiao C; Zhao X; Zhang Y; Zheng X Int J Nanomedicine; 2018; 13():2265-2274. PubMed ID: 29695905 [TBL] [Abstract][Full Text] [Related]
31. Study on the bioavailability of puerarin from Pueraria lobata isoflavone self-microemulsifying drug-delivery systems and tablets in rabbits by liquid chromatography-mass spectrometry. Cui S; Zhao C; Tang X; Chen D; He Z Biomed Chromatogr; 2005 Jun; 19(5):375-8. PubMed ID: 15627278 [TBL] [Abstract][Full Text] [Related]
32. Development of a solidified self-microemulsifying drug delivery system (S-SMEDDS) for atorvastatin calcium with improved dissolution and bioavailability. Yeom DW; Son HY; Kim JH; Kim SR; Lee SG; Song SH; Chae BR; Choi YW Int J Pharm; 2016 Jun; 506(1-2):302-11. PubMed ID: 27125455 [TBL] [Abstract][Full Text] [Related]
33. Borneol Depresses P-Glycoprotein Function by a NF-κB Signaling Mediated Mechanism in a Blood Brain Barrier in Vitro Model. Fan X; Chai L; Zhang H; Wang Y; Zhang B; Gao X Int J Mol Sci; 2015 Nov; 16(11):27576-88. PubMed ID: 26593909 [TBL] [Abstract][Full Text] [Related]
34. A Self-microemulsifying Drug Delivery System (SMEDDS) for a Novel Medicative Compound Against Depression: a Preparation and Bioavailability Study in Rats. Wu L; Qiao Y; Wang L; Guo J; Wang G; He W; Yin L; Zhao J AAPS PharmSciTech; 2015 Oct; 16(5):1051-8. PubMed ID: 25652729 [TBL] [Abstract][Full Text] [Related]
35. [Pharmacokinetics and bioavailability of Puerarin self-microemulsion in Beagle dogs]. Chen XX; Yuan S; Li G; Liang YY; Zhou X; Xie CS; Long CF Zhong Yao Cai; 2011 May; 34(5):750-3. PubMed ID: 21954564 [TBL] [Abstract][Full Text] [Related]
36. Enhanced permeability of blood-brain barrier and targeting function of brain via borneol-modified chemically solid lipid nanoparticle. Song H; Wei M; Zhang N; Li H; Tan X; Zhang Y; Zheng W Int J Nanomedicine; 2018; 13():1869-1879. PubMed ID: 29636606 [TBL] [Abstract][Full Text] [Related]
37. Enhanced blood-brain barrier transport of vinpocetine by oral delivery of mixed micelles in combination with a message guider. Ding J; Sun Y; Li J; Wang H; Mao S J Drug Target; 2017 Jul; 25(6):532-540. PubMed ID: 28151022 [TBL] [Abstract][Full Text] [Related]
38. [Preparation of puerarin liposome and its oral absorption in rat]. Gu YZ; Zhou W; Zhai GX Zhong Yao Cai; 2007 Aug; 30(8):970-3. PubMed ID: 18074848 [TBL] [Abstract][Full Text] [Related]
39. Borneol, a messenger agent, improves central nervous system drug delivery through enhancing blood-brain barrier permeability: a preclinical systematic review and meta-analysis. Zheng Q; Chen ZX; Xu MB; Zhou XL; Huang YY; Zheng GQ; Wang Y Drug Deliv; 2018 Nov; 25(1):1617-1633. PubMed ID: 30334462 [TBL] [Abstract][Full Text] [Related]
40. Self-microemulsifying drug-delivery system for improved oral bioavailability of probucol: preparation and evaluation. Sha X; Wu J; Chen Y; Fang X Int J Nanomedicine; 2012; 7():705-12. PubMed ID: 22359449 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]